Aron M. Knickerbocker

Directeur Général chez Aulos Bioscience, Inc.

Profil

Aron M.
Knickerbocker currently works at Aulos Bioscience, Inc., as President, Chief Executive Officer & Director from 2021, KAHR Medical Ltd., as Chairman, and Phenomic AI, Inc., as Director.
Mr. Knickerbocker also formerly worked at Five Prime Therapeutics, Inc., as President, Chief Executive Officer & Director from 2018 to 2019, Rayzebio, Inc., as Chairman & Chief Executive Officer, ALZA Corp., as Director-Commercial Development from 2000 to 2001, Genentech, Inc., as Senior Director-Business Development from 2005 to 2009, Amgen, Inc., as Senior Manager-Corporate Development from 1996 to 2000, and Bristol Myers Squibb Co., as Scientist.
Mr. Knickerbocker received his undergraduate degree in 1990 from Washington University in St. Louis and Masters Business Admin degree in 1996 from the University of Michigan.

Postes actifs de Aron M. Knickerbocker

Sociétés	Poste	Début
KAHR Medical Ltd.	Président	-
Aulos Bioscience, Inc.	Directeur Général	15/03/2021
Phenomic AI, Inc.	Directeur/Membre du Conseil	-

Anciens postes connus de Aron M. Knickerbocker

Sociétés	Poste	Fin
FIVE PRIME THERAPEUTICS, INC.	Directeur Général	19/09/2019
Genentech, Inc.	Corporate Officer/Principal	01/09/2009
ALZA CORPORATION	Corporate Officer/Principal	01/01/2001
AMGEN INC.	Corporate Officer/Principal	01/01/2000
RAYZEBIO, INC.	Directeur Général	-